Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Emmanuel Nikiforakis"'
Autor:
Serena Valsami, Vassiliki Pappa, Dimitra Rontogianni, Frieda Kontsioti, Efstathios Papageorgiou, John Dervenoulas, Themis Karmiris, Sotirios Papageorgiou, Nikolaos Harhalakis, Nikolaos Xiros, Emmanuel Nikiforakis, Theofanis Economopoulos
Publikováno v:
Haematologica, Vol 92, Iss 10 (2007)
Background and Objectives Although most patients with classical Hodgkin’s lymphoma (CHL) are cured, a significant minority are refractory to treatment. The investigation of biological markers could improve the predictive capacity of clinical stagin
Externí odkaz:
https://doaj.org/article/8ab191eb96464b5c981d86e345173f4c
Autor:
Konstantinos Liapis, Nikolaos Harhalakis, John Apostolidis, Emmanuel Nikiforakis, Fotios Panitsas, Evangelia Charitaki
Publikováno v:
Annals of Pharmacotherapy. 42:1882-1886
Objective: Despite the high prevalence of headache and migraine in the general population, many people do not receive adequate medical attention and treatment. Case Summary: A 29-year-old woman was diagnosed with Bcr-abl+ acute lymphoblastic leukemia
Autor:
Maria Mpakiri, Dimitra Rontogianni, Maria Bouzani, Susanna Delimpassi, Themis Karmiris, Emmanuel Nikiforakis, John Apostolidis
Publikováno v:
The Oncologist. 11:923-928
The purpose of this study was to evaluate the use of combination anthracycline-based immunochemotherapy in intravascular lymphoma (IVL). This is an extremely rare, disseminated, and aggressive extranodal CD20+ non-Hodgkin's lymphoma (NHL) with poor o
Autor:
E. Grigoriou, Nikolaos Harhalakis, John Apostolidis, Themistokles Karmiris, E. Spanou, J. Baltadakis, Chrisanthi H. Mitsouli, Dimitri Karakasis, Maria Bakiri, M. Tsantekidou, H. Mihalakeas, Maria Pagoni, Emmanuel Nikiforakis
Publikováno v:
Leukemia & Lymphoma. 44:1523-1528
The current management of early stage Hodgkin's disease (HD) is usually based on clinical staging, combined modality therapy and the use of less toxic chemotherapy regimens. This approach entails high cure rates, while ensures less long term toxicity
Autor:
Demitris Kousiafes, Emmanuel Nikiforakis, John Apostolidis, Nikolaos Harhalakis, Themis Karmiris, Marina Tsandekidi, Chrisanthi H. Mitsouli, Demitris Karakasis, Maria Pagoni, Maria Bakiri
Publikováno v:
Blood. 98:2875-2877
In a recent report on adults with idiopathic thrombocytopenic purpura (ITP), Portielje et al[1][1] presented limited data on the morbidity and mortality attributed to the systemic effects of short-course corticosteroids in the context of initial trea
Autor:
loannis Baltadakis, Konstantinos Liapis, loannis Apostolidis, Eirini Grispou, Olga Paniara, Emmanuel Nikiforakis, Vicky Kvriazi, Dimitri Karakasis, Aikaterini Manaka, Nicholas Harhalakis, Zoe Poulopoulou, Constantine-George Balotis, Mary Anagnostopoulou, Eirini Bika
Publikováno v:
International Journal of Infectious Diseases. 12
Autor:
Chrisanthi Mentzikof-Mitsouli, Dimitrios T. Trafalis, Christos Tsigris, Elias Poulakidas, Violeta Kapsimali, Xenofon Papanicolaou, Emmanuel Nikiforakis, Nikolaos Harhalakis
Publikováno v:
Oncology Reports.
Among various laboratory and clinical features megakaryocytopoiesis and platelet (PLT) counts have been previously insufficiently evaluated for their prognostic significance in acute myelogenous leukaemia (AML). We studied several clinical and labora
Autor:
John Dervenoulas, Serena Valsami, Frieda Kontsioti, Dimitra Rontogianni, Themis Karmiris, Efstathios Papageorgiou, Nikolaos Xiros, Emmanuel Nikiforakis, Vassiliki Pappa, Sotirios G. Papageorgiou, Theofanis Economopoulos, Nikolaos Harhalakis
Publikováno v:
Haematologica. 92(10)
Background and Objectives Although most patients with classical Hodgkin’s lymphoma (CHL) are cured, a significant minority are refractory to treatment. The investigation of biological markers could improve the predictive capacity of clinical stagin
Autor:
Erini Grigoriou, Marina Tsantekidou, Christos Naum, Panagiotis Kanavaros, Vassiliki Galani, Theodore Argyrakos, Themis Karmiris, Violeta Kapsimali, Catherine Pantelidaki, Dimitra Rontogianni, Nikos Harhalakis, Emmanuel Nikiforakis
Blastic Natural Killer (NK)-cell lymphoma is a relatively new entity which has been recently included in the WHO classification. CD4 expression is observed in most cases of blastic NK-cell lymphomas and has been related with skin tropism. We report a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea680f1eb226672a1a8b57ecff5ea3c7
http://olympias.lib.uoi.gr/jspui/handle/123456789/23448
http://olympias.lib.uoi.gr/jspui/handle/123456789/23448
Autor:
Constantinos Tsatalas, Maria Bouzani, Dimitra Rondogianni, Nikolaos Harhalakis, Emmanuel Nikiforakis, John Apostolidis
Publikováno v:
International Journal of Surgical Pathology. 13:125-126